AVAXZIPEN LIMITED, registered in England and Wales with registration number 10908112, was established on August 9, 2017, and is currently an active limited company. The company’s registered address is 120a&B Olympic Avenue, Milton Park, Abingdon, OX14 4SA. AVAXZIPEN LIMITED operates within the industry classified under SIC 72190 – None. The company’s website indicates it focuses on “Other research and experimental development on natural sciences and engineering,” specifically concentrating on “Thermally Stable Solid Dose Needle Free Vaccines.” The company size is listed as “Unknown” on the website. Financial records for the period ending December 31, 2024, show no charges and indicate the company is not insolvent. The company is a Limited company. Regarding visa status, AVAXZIPEN LIMITED employs a Skilled Worker, currently rated as a Worker (A rating). The company’s operations appear to be centered around research and development, with a particular emphasis on vaccine technology. Due to the limited publicly available information, the precise scale of operations or employee count remains undetermined, aligning with the website’s designation of an “Unknown” company size. Further investigation would be required to ascertain the scope of its international presence and hiring activities, as these are also currently listed as “Unknown.”

AVAXZIPEN LIMITED, registered in England and Wales with registration number 10908112, was established on August 9, 2017, and is currently an active limited company. The company’s registered address is 120a&B Olympic Avenue, Milton Park, Abingdon, OX14 4SA. AVAXZIPEN LIMITED operates within the industry classified under SIC 72190 – None. The company’s website indicates it focuses on “Other research and experimental development on natural sciences and engineering,” specifically concentrating on “Thermally Stable Solid Dose Needle Free Vaccines.” The company size is listed as “Unknown” on the website. Financial records for the period ending December 31, 2024, show no charges and indicate the company is not insolvent. The company is a Limited company. Regarding visa status, AVAXZIPEN LIMITED employs a Skilled Worker, currently rated as a Worker (A rating). The company’s operations appear to be centered around research and development, with a particular emphasis on vaccine technology. Due to the limited publicly available information, the precise scale of operations or employee count remains undetermined, aligning with the website’s designation of an “Unknown” company size. Further investigation would be required to ascertain the scope of its international presence and hiring activities, as these are also currently listed as “Unknown.”